文献速递中毒与环境急症心脑血管急症重症综合管理与镇静镇痛

急性拉莫三嗪过量:已发表成人及儿科病例的系统综述

Acute lamotrigine overdose: a systematic review of published adult and pediatric cases.
PubMed 文献 · Clin Toxicol (Phila) · 2017-09-01
一句话结论多数拉莫三嗪过量仅轻度或无毒性,但成人血药浓度>25 mg/L或≤3.5岁儿童摄入≥525 mg时可能出现严重中枢抑制、癫痫、心脏传导延迟、宽QRS心动过速甚至死亡。

该系统综述检索8个数据库(截止2014年4月,2017年5月31日更新),纳入48篇文献共51例急性或急性-on-慢性拉莫三嗪过量且至少报告一次血药浓度的病例。病例以成人为主(70.6%),危及生命的表现包括癫痫(55%)、GCS≤8(20%)、低血压(12%)、宽QRS心动过速及心脏骤停(6%)。单药暴露25例(成人13例、儿科12例)中,2例成人死亡(摄入4 g和7.5 g),8例儿科病例出现癫痫(均≤3.5岁,75%无基础癫痫病,摄入≥525 mg)。儿科最低癫痫相关血药浓度为3.8 mg/L,成人为25.6 mg/L,提示儿童可能更易发生中枢神经毒性;心血管毒性主要见于成人(阈值>25 mg/L)。干预包括苯二氮䓬类(53%)、丙泊酚或巴比妥类(14%)、碳酸氢钠(20%)、脂质治疗(12%)及体外清除(10%);碳酸氢钠在9例传导延迟中4例无反应,其中2例后续对脂质治疗有反应。

要点

  • 成人拉莫三嗪血药浓度>25 mg/L时可能发生严重毒性,心血管毒性主要见于成人,阈值>25 mg/L。
  • ≤3.5岁儿童摄入≥525 mg可能出现严重中枢抑制和癫痫,75%无基础癫痫病。
  • 儿科最低癫痫相关血药浓度为3.8 mg/L,成人为25.6 mg/L,提示儿童可能更易发生中枢神经毒性。
  • 危及生命的表现包括癫痫(55%)、GCS≤8(20%)、低血压(12%)、宽QRS心动过速和心脏骤停(6%)。
  • 碳酸氢钠在9例传导延迟中4例无反应,其中2例后续对脂质治疗有反应。

适用人群与场景

  • 急性或急性-on-慢性拉莫三嗪过量且至少报告一次血药浓度的成人及儿科病例。
  • 排除慢性中毒、治疗性使用不良反应研究及动物研究。

诊断标准与关键阈值

  • 成人血药浓度>25 mg/L时可能发生严重毒性。
  • ≤3.5岁儿童摄入≥525 mg可能出现严重中枢抑制和癫痫。
  • 儿科最低癫痫相关血药浓度为3.8 mg/L,成人为25.6 mg/L。

处置流程与药物剂量

  • 苯二氮䓬类用于53%的病例。
  • 丙泊酚或巴比妥类用于14%的病例。
  • 碳酸氢钠用于20%的病例,9例传导延迟中4例无反应。
  • 脂质治疗用于12%的病例,碳酸氢钠无反应的4例中2例后续对脂质治疗有反应。
  • 体外清除用于10%的病例。

红旗征与不能漏的情况

  • 癫痫(55%)。
  • GCS≤8(20%)。
  • 低血压(12%)。
  • 宽QRS心动过速和心脏骤停(6%)。

研究设计与关键结果

  • 系统综述检索8个数据库(截止2014年4月,2017年5月31日更新),纳入48篇文献共51例病例。
  • 病例以成人为主(70.6%)。
  • 单药暴露25例(成人13例、儿科12例)中,2例成人死亡(摄入4 g和7.5 g),8例儿科病例出现癫痫(均≤3.5岁,75%无基础癫痫病,摄入≥525 mg)。

证据类型、等级与局限

  • 证据类型:系统综述(病例报告汇总)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 成人拉莫三嗪过量血药浓度>25 mg/L时需警惕严重毒性。
  • ≤3.5岁儿童摄入≥525 mg时需警惕严重中枢抑制和癫痫。
  • 传导延迟对碳酸氢钠无反应时可考虑脂质治疗(作者基于2例后续有反应的病例)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: Lamotrigine is a broad-spectrum anticonvulsant commonly used to treat seizure and bipolar mood disorders. Evidence from case series and retrospective studies indicate that lamotrigine overdose is usually benign. However, there are reported cases of cardiac arrest and mortality following lamotrigine overdose. We undertook a systematic review of the literature on lamotrigine overdoses to better understand the clinical severity, the relevance of serum concentrations, and therapeutic interventions for overdose.

OBJECTIVES: To characterize manifestations of acute lamotrigine overdose, determine if serum concentrations predict poisoning severity, and evaluate the effectiveness of overdose management interventions.

METHODS: We performed a literature search across eight databases, including Medline, EMBASE, and the Cochrane Library, from database inception to April 2014. Major bibliographic databases were updated on 31 May 2017. Articles were eligible if they described acute or acute on chronic lamotrigine overdose. At least one serum lamotrigine concentration had to be reported for inclusion. Reports on chronic poisoning, studies describing adverse effects of therapeutic use, and animal studies were excluded.

RESULTS: We retrieved 6238 records; 48 (51 cases) met the inclusion criteria. Cases primarily involved adults (70.6%). Potentially life-threatening symptoms of overdose included seizures (55%), Glasgow Coma Scale ≤8 (20%), hypotension (12%), and wide complex tachycardia (WCT) and cardiac arrest (6%). Among the 25 cases exposed to lamotrigine alone (13 adult; 12 pediatric), 2 adult fatalities occurred (4 g and 7.5 g ingested) and 8 pediatric cases experienced seizures (all children ≤3.5-years-old, 75% without an underlying seizure disorder, ≥ 525 mg ingested). The lowest seizure-associated serum concentration was 3.8 mg/L and 25.6 mg/L for pediatric and adult patients, respectively, suggesting children may be more susceptible to CNS toxicity. Cardiovascular toxicities occurred primarily in adult patients (threshold >25 mg/L). Overdose interventions included benzodiazepines (53%), propofol or barbiturates (14%), NaHCO3 (20%), lipid therapy (12%), and extracorporeal elimination (10%). NaHCO3 yielded no response in four of nine cases with conduction delays; however, two of the four cases subsequently responded with lipid therapy.

CONCLUSIONS: Most cases reporting lamotrigine exposures observed mild or no toxicity; however, large exposures were associated with severe CNS depression, seizures, cardiac conduction delays, wide complex tachycardia, and death. In adults with a serum concentration >25 mg/L, severe toxicity may occur. In patients ≤3.5 years of age, ingestions of ≥525 mg may produce severe CNS depression and seizures.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Alyahya B, Friesen M, Nauche B, et al. Acute lamotrigine overdose: a systematic review of published adult and pediatric cases. Clin Toxicol (Phila). 2017. PMID: 28862044. doi:10.1080/15563650.2017.1370096

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。